Median Technologies SA (FRA:4ZG)

Market Cap	113.44M
Revenue (ttm)	23.38M
Net Income (ttm)	-21.99M
Shares Out	n/a
EPS (ttm)	-1.16
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	10
Open	3.105
Previous Close	3.175
Day's Range	3.105 - 3.105
52-Week Range	1.238 - 5.190
Beta	n/a
RSI	55.74
Earnings Date	Apr 28, 2026

About Median Technologies

Median Technologies SA develops and markets software products and platforms for medical image analysis in France, the United States, Canada, the United Kingdom, China, and internationally. The company offers iBiops, an end-to-end AI-powered technology software as a medical device for early diagnosis of cancers and fibrotic diseases; iSee for image analysis services in clinical trials; and iCRO, which engages in the sale of imaging services for clinical trials in oncology using software. The company was founded in 2002 and is based in Valbonne, ...

• Industry: Computer Integrated Systems Design
• Founded: 2002
• Employees: 225
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 4ZG

Financial Performance

In 2024, Median Technologies's revenue was 22.96 million, an increase of 0.79% compared to the previous year's 22.78 million. Losses were -25.24 million, 9.83% more than in 2023.